Paper Details 
Original Abstract of the Article :
INTRODUCTION: Cancer remains a worldwide threat, having caused almost 10 million deaths in 2020. The American Cancer Society has identified both known and probable carcinogens, including commonly used drugs. The aim of this study is to describe the drugs most frequently reported in the occurrence of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.therap.2023.11.003

データ提供:米国国立医学図書館(NLM)

Drug-Induced Tumoral Disease

This research ventures into the complex and often overlooked realm of drug-induced cancer, analyzing a vast database of adverse drug reaction reports to identify drugs most frequently associated with the development of tumors. The authors, like meticulous desert archaeologists piecing together fragments of history, sought to uncover the hidden links between certain drugs and the risk of cancer.

Unmasking Drug-Induced Cancers

The study's findings highlight a range of drugs that have been linked to an increased risk of cancer. This discovery, much like a desert explorer uncovering a hidden spring in a barren landscape, underscores the importance of understanding the potential risks associated with certain medications, particularly those that may have unexpected side effects.

Implications for Drug Safety

The study emphasizes the need for ongoing monitoring and vigilance in identifying potential drug-induced cancers. This vigilance, much like a desert community's watchful eye on its environment, aims to ensure patient safety and minimize the risk of adverse drug reactions.

Dr.Camel's Conclusion

This research sheds light on the critical issue of drug-induced cancer, underscoring the need for continuous surveillance and a comprehensive approach to drug safety. It's a reminder that the quest for better health comes with its own set of challenges, much like the desert's unforgiving landscape.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-02
Further Info :

Pubmed ID

38042752

DOI: Digital Object Identifier

10.1016/j.therap.2023.11.003

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.